CONBA(SH:600572)2020-04-27 16:00Financial Performance - Net profit attributable to shareholders increased by 2.20% to CNY 182,313,527.36 year-on-year[10] - Operating income decreased by 3.50% to CNY 1,678,628,374.37 compared to the same period last year[10] - The net profit excluding non-recurring gains and losses decreased by 22.18% to CNY 117,226,813.13 compared to the same period last year[10] - The net profit attributable to shareholders for the first quarter is 120.058 million RMB, representing a year-on-year increase of approximately 51%[21] - The net profit attributable to shareholders after deducting non-recurring gains and losses is 106.100 million RMB, showing a year-on-year growth of about 71%[21] - Net profit for Q1 2020 was CNY 200,641,709.18, an increase from CNY 192,211,754.22 in Q1 2019, indicating improved profitability[55] Revenue and Sales - Revenue from major brand products reached CNY 1,096,000,000, a year-on-year increase of 32.93%[15] - Sales of "Xutong" Dan Shen Chuan Xiong Injection decreased by 80.72%, impacting overall revenue significantly[14] - Total revenue for Q1 2020 was CNY 1,678,628,374.37, a decrease of 3.9% compared to CNY 1,739,453,895.72 in Q1 2019[52] - The company's operating revenue for Q1 2020 was approximately ¥123.12 million, a decrease of 23.9% compared to ¥161.76 million in Q1 2019[58] Cash Flow - Cash flow from operating activities increased by 48.44% to CNY 283,116,391.03 year-on-year[10] - The net cash flow from operating activities increased by 48.44% to ¥283,116,391.03, mainly due to reduced sales and management expenses[32] - The net cash flow from investing activities surged by 185.17% to ¥89,791,646.50, driven by the receipt of equity transfer payments[32] - The net cash flow from operating activities was $381,628,415.51, a significant increase compared to $97,600,926.42 in the previous period, indicating strong operational performance[66] Assets and Liabilities - Total assets increased by 3.26% to CNY 10,182,277,147.91 compared to the end of the previous year[10] - The company's current assets totaled CNY 5,266,602,417.57 as of March 31, 2020, compared to CNY 4,797,594,684.17 at the end of 2019, indicating an increase of about 9.76%[41] - Total liabilities increased to CNY 5,054,685,963.21 from CNY 4,917,631,823.18, representing a rise of about 2.79%[46] - The company's equity attributable to shareholders increased to CNY 4,830,859,903.29 from CNY 4,662,379,296.95, showing a growth of approximately 3.6%[46] Investments - Investment income from the transfer of shares in JHBP(CY) amounted to CNY 58,555,800 during the reporting period[20] - The company’s investment income decreased by 247.97% to ¥35,458,961.20 due to the disposal of JHBP(CY)[29] - The company completed the transfer of 24,486,666 shares of JHBP(CY) Holdings Limited for a total of $28,784,857.43[33] Shareholder Information - The company holds 97,282,881 shares in its repurchase account, accounting for 3.65% of the total share capital[24] - The largest shareholder, Kang En Bei Group Co., Ltd., holds 707,248,411 shares, representing 26.52% of the total shares, with 208,430,000 shares pledged[25] - The second-largest shareholder, Hu Jiqiang, holds 176,079,085 shares, which is 6.60% of the total shares, with 127,020,000 shares pledged[25] Other Financial Metrics - The company achieved a basic earnings per share of CNY 0.071, an increase of 2.90% year-on-year[10] - The total impact of non-recurring items on net profit is 65.087 million RMB[21] - Government subsidies recognized during the period amount to 25.323 million RMB, related to revenue[21] - Other operating income and expenses include a donation expense of 10.852 million RMB[21]